CFFI insider files Form 144 to sell 1,205 vested RSA shares on Nasdaq
Rhea-AI Filing Summary
C&F Financial Corp (CFFI) Form 144: The filer notifies a proposed sale of 1,205 common shares by or for the account of a person who acquired those shares as vested RSAs on 03/01/2024. The broker listed is C&F Wealth Management, Midlothian VA and the securities are to be sold approximately on 08/19/2025 on Nasdaq. The filing reports an aggregate market value of $81,289.30 for the shares and states there were 39,607 shares outstanding at the time of the notice. The filer represents no undisclosed material adverse information and attests to compliance with Rule 144.
Positive
- Transparent disclosure: The filer provides required Rule 144 details including quantity, acquisition date, and broker.
- Sale stems from equity compensation: Shares were acquired as vested RSAs, indicating routine employee/insider compensation conversion.
Negative
- Insider sale proposed: 1,205 shares with aggregate market value of $81,289.30 are planned to be sold on 08/19/2025, which could be perceived negatively by some investors.
Insights
TL;DR: Insider intends to sell 1,205 vested RSA shares worth $81,289.30 on Nasdaq; routine disclosure under Rule 144.
This Form 144 records a proposed sale of 1,205 common shares acquired via vested restricted stock awards on 03/01/2024. The planned sale date is 08/19/2025, through C&F Wealth Management. The filing provides required transparency about timing, quantity, acquisition method, and aggregate market value. As presented, the notice contains no additional operational or financial information about the issuer; its primary effect is disclosure of a potential insider sale rather than a change to company fundamentals.
TL;DR: Filing documents a compliant, scheduled sale of equity compensation; no governance red flags are evident from this notice alone.
The document shows a sale of shares that were granted as RSAs and vested, with payment characterized as equity compensation. The signature/attestation language affirms absence of undisclosed material adverse information. From a governance perspective, this is a routine disclosure fulfilling Rule 144 requirements. There is no information here about additional related-party transactions, timing under an insider trading plan, or deviations from standard disclosure practice.